Comparison of Intubating Conditions at 60 Seconds with Cisatracurium 4*ED95 Dose and Cisatracurium 2*ED95 Dose Plus Priming Dose and Low Dose Ketamine

被引:0
|
作者
Daga, Rahul G. [1 ]
Bali, Irbinder Kour [2 ]
Patil, Pushparaj Nilkanth [3 ]
Daga, Rohit Ghanshyamdas [1 ,4 ]
Daga, Rashmi [5 ]
Devika, G. S. [6 ]
机构
[1] Suretech Hosp, Dept Anesthesia & Crit Care, Nagpur, Maharashtra, India
[2] MMIMSR, Dept Pathol, Ambala, Haryana, India
[3] NAMO Meri Silvassa, DNH & DD UT, Dept Pediat, Diu, India
[4] Trauma Care Ctr, Med Officer Orthopaed Surgeon, Hinganghat, Maharashtra, India
[5] Dr RR Kambe Dent Coll & Hosp, Akola, Maharashtra, India
[6] Cherraans Coll Pharm, Dept Pharmaceut Anal, Coimbatore, Tamil Nadu, India
关键词
Cisatracurium; intubating conditions; low dose ketamine; RAPID TRACHEAL INTUBATION; ROCURONIUM; ATRACURIUM; INDUCTION;
D O I
10.4103/jpbs.jpbs_265_23
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: To compare the intubating conditions at 60 seconds between 4*ED95 dose of cisatracurium and 2*ED95 dose of cisatracurium in combination with priming and low dose ketamine Primary Objective: jaw relaxation for laryngoscopy, vocal cord position on laryngoscopy, and coughing or bucking response to intubation. Secondary Objective: To compare the hemodynamic changes up 10 minutes after intubation in the two groups. In this prospective study, a total of 68 patients were undergoing general anesthesia for surgery with placement of endotracheal tube placement. Patients will be divided into two groups comprising 34 patients each. The patients were allocated one of the two groups by computerized randomization. *Group A received bolus dose of cisatracurium which is 0.2 mg/kg (4*ED95). **Group B received cisatracurium in dose of 0.1 mg/kg (2*ED95) with priming (which is 10% of the bolus dose) and low dose ketamine of about 0.5 mg/kg. It was possible to achieve acceptable laryngoscopy and intubating condition in both the groups within 90 seconds. When grades of laryngoscopy and ease of intubation were compared, 2*ED95 dose along with priming plus low dose ketamine produced superior results than 4*ED95 group. When the mean arterial pressure and pulse rate were compared between the two groups, it was observed that mean arterial pressure and pulse rate were only slightly higher in the 2*ED95 along with priming and ketamine.
引用
收藏
页码:S960 / S963
页数:4
相关论文
共 33 条
  • [31] Pomalidomide Plus Low-Dose Dexamethasone (Pom/Dex) in Relapsed Lenalidomide Refractory Myeloma: Long Term Follow up and Comparison of 2 Mg Vs 4 Mg Doses
    Lacy, Martha Q.
    LaPlant, Betsy R.
    Laumann, Kristina M.
    Kumar, Shaji
    Gertz, Morie A.
    Hayman, Suzanne R.
    Buadi, Francis
    Dispenzieri, Angela
    Lust, John A.
    Kapoor, Prashant
    Leung, Nelson
    Russell, Stephen
    Dingli, David
    Go, Ronald S.
    Gonsalves, Wilson I.
    Fonseca, Rafael
    Bergsagel, P. Leif
    Roy, Vivek
    Sher, Taimur
    Ailawadhi, Sikander
    Chanan-Khan, Asher
    Stewart, A. Keith
    Reeder, Craig B.
    Rajkumar, S. Vincent
    Mikhael, Joseph R.
    BLOOD, 2014, 124 (21)
  • [32] Efficacy of imeglimin treatment versus metformin dose escalation on glycemic control in subjects with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: A multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study)
    Takahashi, Akihiro
    Nomoto, Hiroshi
    Yokoyama, Hiroki
    Yokozeki, Kei
    Furusawa, Sho
    Oe, Yuki
    Kameda, Reina
    Kawata, Shinichiro
    Miyoshi, Arina
    Nagai, So
    Miya, Aika
    Kameda, Hiraku
    Nakamura, Akinobu
    Atsumi, Tatsuya
    MEGMI Study Group
    DIABETES OBESITY & METABOLISM, 2025, 27 (03): : 1466 - 1476
  • [33] Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study)
    Nomoto, Hiroshi
    Takahashi, Akihiro
    Nakamura, Akinobu
    Kurihara, Hiroyoshi
    Takeuchi, Jun
    Nagai, So
    Taneda, Shinji
    Miya, Aika
    Kameda, Hiraku
    Cho, Kyu Yong
    Miyoshi, Hideaki
    Atsumi, Tatsuya
    BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (06)